Skip to main content

Table 1 Demographics, comorbidities, clinical features and quality of life assessment of all necrotizing soft-tissue infection patients included

From: Long-term quality of life in necrotizing soft-tissue infection survivors: a monocentric prospective cohort study

 

Available data

All patients n  =  49

Demographics

 Age, years, median [IQR]

49

60 [53–70]

 Male gender

30 (61.2)

Comorbidities

 Diabetes mellitus

49

18 (36.7)

 Immunodeficiency

12 (24.5)

  Cancer

4 (8.2)

  Corticosteroids

8 (16.3)

 Obliterating arteritis of the lower limbs

6 (12.2)

 Chronic kidney disease

3 (6.1)

 Chronic obstructive pulmonary disease

6 (12.2)

 Cardiac disease

12 (24.5)

 Liver cirrhosis

1 (2.0)

 Chronic alcohol consumption

5 (10.2)

 Obesity

15 (30.6)

Clinical characteristics

 ICU admission

49

24 (49.0)

 SAPS IIa, median [IQR]

39

26 [18–37]

 SOFA scorea, median [IQR]

45

1 [0–7]

 Mechanical ventilation

49

11 (22.5)

 Shockb

47

18 (38.3)

 Duration of hospital stay, days, median [IQR]

49

21 [12–32]

 NSTI topography

49

 

  Limbs

41 (83.7)

  Trunk and/or abdomino-perineal

9 (18.4)

 Body surface affected, %; median [IQR]

42

4 [2–4.5]

 Circumferential infection

45

7 (15.6)

 Articular skin involvement

49

23 (46.9)

 Number of surgical debridements, median [IQR]

49

1 [1, 2]

Quality of life assessment

 Time between discharge and interview, years; median [IQR]

49

1.5 [1.1–2.4]

 Self-assessed global quality of life, median [IQR]

49

65 [50–80]

 Functioning level/independence

  ADL, median [IQR]

48

6 [5.5–6]

  IADL, median [IQR]

49

7 [5–8]

 Mental health

  HAD-A, median [IQR]

49

5 [3–9]

  HAD-A  ≥  8

14 (28.6)

  HAD-D, median [IQR]

46

3 [1–6]

  HAD-D  ≥  5

17 (37.0)

  IES-R, median [IQR]

49

9 [5–22]

  IES-R  ≥  33

10 (20.4)

 General quality of life outcomes

  Current place of residence

   Sheltered housing

49

–

   Care home

1 (2.0)

   Private home without assistance

41 (83.7)

   Private home with assistance

7 (14.3)

  Sequelae related to NSTI

31 (63.3)

  Amputations

9 (18.4)

  Walking distance

   Not able to walk

49

2 (4.1)

   < 50 m

5 (10.2)

   50–200 m

6 (12.2)

   200–500 m

4 (8.2)

   > 500 m

32 (65.3)

 Rehospitalizations

49

25 (51.0)

 Current employment status

  Full-time employment/studies

49

10 (20.4)

  Part-time employment/studies

2 (4.1)

  Occasional employment

–

  Unemployed

2 (4.1)

  Retired

23 (46.9)

  Long-term disability

12 (24.5)

 Change in employment status since illness

49

18 (36.7)

 Change in family status

49

6 (12.2)

  In a relationship

1 (25.0)

  Separated

3 (75.0)

  Parenthood

1 (16.7)

 Augmented alcohol consumption

49

1 (2.0)

 Augmented tobacco consumption

1 (2.0)

 Augmented drug consumption

0 (0.0)

  1. Qualitative variables are shown as n (%)
  2. SAPS II Simplified Acute Physiology Scale II; SOFA Sequential Organ Failure Assessment; NSTI necrotizing soft tissue infection; ADL Activities of Daily Living scale; IADL Instrumental Activities of Daily Living scale; HAD-A Hospital Anxiety and Depression scale-Anxiety; HAD-D Hospital Anxiety and Depression scale-Depression; IES-R Impact of Events Scale-Revised
  3. aWithin 24 h of hospital admission
  4. bDefined as need for vasopressors during the course of intensive care unit (ICU) stay